Buy Salbutamol - Proper Labs [100Tabs/4mg] in Europe. €35.00
Buy Salbutamol - Proper Labs [100Tabs/4mg] in Europe. €35.00

Salbutamol - Proper Labs [100Tabs/4mg]



Salbutamol, also known as albuterol, is a medication commonly used to alleviate symptoms associated with asthma and chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. As a fast-acting bronchodilator and reliever medication, it plays a crucial role in managing conditions characterized by wheezing, coughing, chest tightness, and breathlessness.

Key points about salbutamol include:

  1. Class of Medication: Salbutamol belongs to the class of medications known as short-acting beta-2 adrenergic agonists.

  2. Mechanism of Action: It stimulates the beta-2 adrenoceptors in the bronchial muscles, which are the smooth muscles lining the bronchi. By doing so, salbutamol induces relaxation and dilation of the bronchi, leading to a widened airway for a short duration (typically 4 to 6 hours). This action facilitates easier breathing.

  3. Medical Conditions Treated: Salbutamol is primarily prescribed for individuals with asthma and COPD. It helps manage acute symptoms and serves as a rescue medication during exacerbations.

  4. Availability: Both branded and generic formulations of salbutamol are available globally. In many countries, it is known by its generic name, salbutamol, following the International Nonproprietary Name (INN) system. In the United States, it is known as albuterol (marketed under brand names such as ProAir and Ventolin) based on the United States Adopted Names (USAN) system.

  5. Mode of Administration: Salbutamol is commonly administered through inhalation, allowing for direct delivery to the bronchial muscles.

  6. Branding: Salbutamol is often marketed under the brand name Ventolin, which is well-recognized in the UK and other regions.

Salbutamol has played a significant role in providing relief to individuals with respiratory conditions, contributing to improved quality of life for those affected by asthma and COPD. It has been available in the medical landscape since the late 1960s (in the UK) and the 1980s (in the US).

16 other products in the same category: